Stock comparison
Integra LifeSciences
IART$1.34BHealthcare Market cap, Sector
Sanofi Consumer Healthcare India Limited
SANOFICONR.BO$104.05BHealthcare Market cap, Sector
Overall winner
Sanofi Consumer Healthcare India Limited
IART 07 SANOFICONR.BO
Wins on the combined sum of fit scores across all four strategies. Per-strategy breakdown below.
Scored across Buffett, Graham, Lynch and Greenblatt - plus a side-by-side metric table covering valuation, quality, growth and balance sheet.
Fit scores by strategy
IART0wins
7winsSANOFICONR.BO
26F
B78
40F
A89
23F
B83
21F
B77
40F
A91
22F
A86
15F
A85
Side-by-side metrics
| Metric | IART | SANOFICONR.BO |
|---|---|---|
| Market cap | $1.34B | $104.05B Winner |
| P/E (TTM) | Winner: - | 44.0x |
| EV/EBIT | 42.6x | 31.7x Winner |
| ROIC (TTM) | 3.49% | 59.15% Winner |
| Gross margin | 53.21% | 68.13% Winner |
| Net margin | -30.15% | 27.35% Winner |
| Revenue CAGR 5y | 1.47% | 27.01% Winner |
| EPS CAGR 5y | - | 20.67% |
| Debt / Equity | 2.0x | 0.1x Winner |
| Dividend yield | 0.0% | - |
Where each one wins
The metrics with the biggest gap between the two - sorted so the most decisive edges read first.
IART leads on
- P/E (TTM)-vs 44.0x+105%
SANOFICONR.BO leads on
- Net margin27.35%vs -30.15%+191%
- Market cap$104.05Bvs $1.34B+99%
- Debt / Equity0.1xvs 2.0x+97%
- Revenue CAGR 5y27.01%vs 1.47%+95%
Related on invest-like
Key terms in this analysis
Educational tool. Fit scores are deterministic projections from public financials onto each investor's published criteria - not personal recommendations or advice.